4.7 Article

Novel Endometrial Cancer Models Using Sensitive Metastasis Tracing for CXCR4-Targeted Therapy in Advanced Disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

Self-assembling protein nanocarrier for selective delivery of cytotoxic polypeptides to CXCR4+ head and neck squamous cell carcinoma tumors

Elisa Rioja-Blanco et al.

Summary: This study validates the potential use of T22-GFP-H6 as a nanocarrier to selectively deliver drugs to CXCR4(+) tumors in HNSCC, showing promising therapeutic effects without causing histological alterations in normal organs.

ACTA PHARMACEUTICA SINICA B (2022)

Review Biochemistry & Molecular Biology

Fertility Sparing Treatments in Endometrial Cancer Patients: The Potential Role of the New Molecular Classification

Anna Franca Cavaliere et al.

Summary: Endometrial cancer is the most common gynecological malignancy, and fertility sparing treatments offer hope for young cancer patients who wish to preserve their ability to have children while undergoing treatment. Advances in molecular biology and the refined clinical and prognostic classification of endometrial cancer based on The Cancer Genome Atlas allow for the selection of patients who can undergo fertility sparing treatments with increased oncological safety.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Biochemistry & Molecular Biology

Fertility-Sparing Approach in Women Affected by Stage I and Low-Grade Endometrial Carcinoma: An Updated Overview

Giuseppe Gullo et al.

Summary: Fertility-sparing approach is suitable for early-stage Type I EC, with emphasis on pharmaceutical treatment and follow-up.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Oncology

Isoliquiritigenin Reverses Epithelial-Mesenchymal Transition Through Modulation of the TGF-β/Smad Signaling Pathway in Endometrial Cancer

Hsin-Yuan Chen et al.

Summary: The study aimed to investigate the anti-metastatic potential of ISL on endometrial cancer by reversing EMT through targeting the TGF-beta/Smad signaling pathway. Results from in vitro and in vivo experiments demonstrated that ISL efficiently inhibited cell migration, reduced metastasis, and altered the expression of related proteins.

CANCERS (2021)

Article Multidisciplinary Sciences

An immune competent orthotopic model of endometrial cancer with metastasis

Alyssa M. Fedorko et al.

HELIYON (2020)

Review Immunology

The CXL12/CXCR4/CXCR7 axis in female reproductive tract disease: Review

Graciela Krikun

AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2018)

Review Radiology, Nuclear Medicine & Medical Imaging

CXCR4-directed theranostics in oncology and inflammation

Malte Kircher et al.

ANNALS OF NUCLEAR MEDICINE (2018)

Review Biochemistry & Molecular Biology

Modeling Endometrial Cancer: Past, Present, and Future

Tom Van Nyen et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Article Biochemistry & Molecular Biology

Development of an Image-Guided Orthotopic Xenograft Mouse Model of Endometrial Cancer with Controllable Estrogen Exposure

Gonda F. J. Konings et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Article Oncology

SEOM clinical guidelines for endometrial cancer (2017)

A. Santaballa et al.

CLINICAL & TRANSLATIONAL ONCOLOGY (2018)

Article Biochemistry & Molecular Biology

CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients

S. Lefort et al.

ONCOGENE (2017)

Review Oncology

Molecular approaches for classifying endometrial carcinoma

Josep M. Piulats et al.

GYNECOLOGIC ONCOLOGY (2017)

Article Radiology, Nuclear Medicine & Medical Imaging

CXCR4 Ligands: The Next Big Hit?

Annemiek M. E. Walenkamp et al.

JOURNAL OF NUCLEAR MEDICINE (2017)

Article Oncology

Precise epitope determination of the anti-vimentin monoclonal antibody V9

Lucia Tomiyama et al.

MOLECULAR MEDICINE REPORTS (2017)

Article Multidisciplinary Sciences

QuPath: Open source software for digital pathology image analysis

Peter Bankhead et al.

SCIENTIFIC REPORTS (2017)

Article Nanoscience & Nanotechnology

Cancer-specific uptake of a liganded protein nanocarrier targeting aggressive CXCR4+ colorectal cancer models

Maria Virtudes Cespedes et al.

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2016)

Article Medical Laboratory Technology

Understanding the effect size and its measures

Cristiano Ialongo

BIOCHEMIA MEDICA (2016)

Article Multidisciplinary Sciences

Multimodal Imaging of Orthotopic Mouse Model of Endometrial Carcinoma

Ingfrid S. Haldorsen et al.

PLOS ONE (2015)

Article Multidisciplinary Sciences

Stromal Derived Factor-1 (SDF-1) and Its Receptors CXCR4 and CXCR7 in Endometrial Cancer Patients

Malgorzata Walentowicz-Sadlecka et al.

PLOS ONE (2014)

Article Multidisciplinary Sciences

Integrated genomic characterization of endometrial carcinoma

Gad Getz et al.

NATURE (2013)

Article Oncology

Generation and characterization of orthotopic murine models for endometrial cancer

Silvia Cabrera et al.

CLINICAL & EXPERIMENTAL METASTASIS (2012)

Article Nanoscience & Nanotechnology

Intracellular CXCR4+ cell targeting with T22-empowered protein-only nanoparticles

Ugutz Unzueta et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2012)

Article Oncology

Global Cancer Statistics

Ahmedin Jemal et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2011)

Article Oncology

The CXCR4/CXCL12 axis in endometrial cancer

Stefania Gelmini et al.

CLINICAL & EXPERIMENTAL METASTASIS (2009)